1Melchionda N, Fodani G, Marchesini G, et al. WHO and ADA eriteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance, Int J Obes Relat Metab Disord,2002,26:90-96.
2Krakoff J, Funahashi T, Stehouwer CD, et al. Inflammatory markers,adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care,2003, 26:1745-1751.
3Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponec - tinemia in obesity and type 2 diabetes:dose association with insulin resistance and hyperirmuline - mia. J Clin Endocrinol Metab,2001,86: 1930 -1935.
4Hotta K,Funahashi T,Bodkin NL,et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes ,2001,50: 1126-1133.
5邹大进 李慧.肥胖、炎症与胰岛京抵抗[J].国外医学：内分泌学分册,2004,24:2-2.
6Yokota T, Meka CS, Kouro T, et al. Adipanectin, a fat cell product,influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cycloxygenase - prostaglandin pathway in stromal cells. J Immunol,2003,171 (10):5091-5099.
7Ouchi N,Khara S,Funahashi T,et al. Reciprocal association of C -reactive protein with adiponectin in blood stream and adipose tissue.Circulation, 2003, 107:671-674.
8Greeshnm K, Sherry MD, Panayiotis A, et al. Circulatin - gadiponctin and resistin levels in relation to metabolic factors,inflammatory markers,and vascular reactivity in diabetes. Diabetes Care,2004,27:2450-2457.
